Delphia (USA) Inc. - POSEIDA THERAPEUTICS INC ownership

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 94 filers reported holding POSEIDA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.

Quarter-by-quarter ownership
Delphia (USA) Inc. ownership history of POSEIDA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$54,568
+33.1%
17,717
+12.1%
0.07%
+139.3%
Q2 2022$41,000
-77.5%
15,799
-61.2%
0.03%
-79.4%
Q1 2022$182,00040,7330.14%
Other shareholders
POSEIDA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 2,945,948$5,184,8681.60%
Aisling Capital Management LP 1,043,267$1,836,1500.90%
Knott David M Jr 140,921$2480.10%
XTX Topco Ltd 233,493$410,9480.07%
Pentwater Capital Management LP 5,975,000$10,516,0000.07%
Atom Investors LP 49,413$86,9670.03%
EcoR1 Capital, LLC 676,296$1,190,2810.03%
Forefront Analytics, LLC 26,619$46,8500.03%
FNY Investment Advisers, LLC 11,500$200.02%
CORNERCAP INVESTMENT COUNSEL INC 80,979$142,5230.02%
View complete list of POSEIDA THERAPEUTICS INC shareholders